CHF-5022 is a non-steroidal anti-inflammatory drug, which selectively inhibit the production of beta-amyloid(1-42) (Abeta42). References: Imbimbo BP, Del Giudice E, Cenacchi V, Volta R, Villetti G, Facchinetti F, Riccardi B, Puccini P, Moretto N, Grassi F, Ottonello S, Leon A. In vitro and in vivo profiling of CHF5022 and CHF5074 Two beta-amyloid1-42 lowering agents. Pharmacol Res. 2007 Apr;55(4):318-28. Epub 2007 Jan 16. PubMed PMID: 17292621.

纯度：≥98%

CAS：749269-77-0